Trial Profile
Failure of metformin and sulfonylurea combination therapy: should we stop or continue the use of sulfonylurea in combination with insulin glargine in type 2 diabetes patients in primary care?
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Jun 2012
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Metformin; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DIASULIN
- 03 Jun 2012 Status changed from active, no longer recruiting to completed as reported by Netherlands Trials Register record..
- 05 Mar 2009 New trial record